Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||0.63 x 2887600|
|Ask||0.68 x 990000|
|Day's Range||0.63 - 0.68|
|52 Week Range||0.37 - 0.81|
|PE Ratio (TTM)||-11.05|
|Earnings Date||Aug 17, 2017 - Aug 21, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||1.35|
Cynata Therapeutics Limited (ASX:CYP), a pharmaceuticals, biotechnology and life sciences company based in Australia, received a lot of attention from a substantial price increase on the ASX in the overRead More...
MELBOURNE, Australia, Sept. 05, 2017-- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited, announced today it will be featured as a presenting company at the 19th Annual ...
Clear efficacy data for Cynata’ s proprietary Cymerus™ MSCs in second preclinical study in a clinically-relevant model of asthma Cymerus MSCs caused significantly greater reduction of airway hyperresponsiveness ...